Bottom line
What is ERHSX's expense ratio?
ERHSX's expense ratio is 1.43%, or about $143 a year on every $10,000 invested. That is more expensive than 79% of health care sector funds we track (median 0.96%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Dec 23, 2025
ERHSX fee table
| Net expense ratio | 1.43% |
|---|---|
| Gross expense ratio | 1.46% |
| Management fee | 0.8% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.15% |
| Acquired fund fees | 0.01% |
| Fee waiver / reimbursement | -0.03% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Dec 23, 2025
What ERHSX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| ERHSX | $146 | $459 | $795 | $1,744 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.43% expense ratio costs roughly $76,300 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).
Cheaper alternatives to ERHSX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.